Apoptosis and the liver: Relation to autoimmunity and related conditions

Autoimmunity Reviews

Volumn 2, Issue 1, 2003, Pages 36-42

  Bai, Jingxiang ^a   Odin, Joseph A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bcl 2; Fas; Liver; Tumor necrosis factor

Indexed keywords

APOPROTEIN; FAS ANTIGEN; PROTEIN BCL 2; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; ALLOGRAFT; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DEATH; CELL SURFACE; CYTOTOXIC LYMPHOCYTE; GRAFT REJECTION; HEPATOBILIARY SYSTEM; HOMEOSTASIS; HUMAN; LIGAND BINDING; LIVER CARCINOMA; LIVER DEVELOPMENT; LIVER DISEASE; LIVER GRAFT; LIVER TUMOR; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; VIRUS HEPATITIS; ANIMAL; CYTOTOXIC T LYMPHOCYTE; IMMUNOLOGY; LIVER; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; FAS LIGAND PROTEIN; HOMEOSTASIS; HUMANS; LIVER; LIVER DISEASES; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041880709     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(02)00125-8     Document Type: Review

References (39)

1. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257.
2. Ren Y., Savill J. Apoptosis: the importance of being eaten. Cell Death Differ. 5:1998;563-568.
3. Strasser A., O'Connor L., Dixit V.M. Apoptosis signaling. Annu Rev Biochem. 69:2000;217-245. Review.
4. Nakagawa T., Zhu H., Morishima N., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 403:2000;98-103.
5. Terada T., Nakanuma Y. Detection of apoptosis and expression of apoptosis-related proteins during human intrahepatic bile duct development. Am J Pathol. 146:(1):1995;67-74.
6. Sergi C., Adam S., Kahl P., Otto H.F. Study of the malformation of ductal plate of the liver in Meckel syndrome and review of other syndromes presenting with this anomaly. Pediatr Dev Pathol. 3:(6):2000;568-583.
7. Harada K., Iwata M., Kono N., Koda W., Shimonishi T., Nakanuma Y. Distribution of apoptotic cells and expression of apoptosis-related proteins along the intrahepatic biliary tree in normal and non-biliary diseased liver. Histopathology. 37:(4):2000;347-354.
8. Fox C.K., Furtwaengler A., Nepomuceno R.R., Martinez O.M., Krams S.M. Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis. Liver. 21:(4):2001;272-279.
9. Harada K., Ozaki S., Gershwin M.E., Nakanuma Y. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology. 26:(6):1997;1399-1405.
10. Higuchi H., Bronk S.F., Takikawa Y., et al. The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis. J Biol Chem. 276:(42):2001;38610-38618.
11. Botla R., Spivey J.R., Aguilar H., Bronk S.F., Gores G.J. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J Pharmacol Exp Ther. 272:(2):1995;930-938.
12. Odin J.A., Huebert R.C., Casciola-Rosen L., LaRusso N.F., Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest. 108:(2):2001;223-232.
13. Rosen A., Casciola-Rosen L., Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med. 181:(4):1995;1557-1561.
14. Matsumura S., Van De Water J., Kita H., et al. Contribution to antimitochondrial antibody production: cleavage of pyruvate dehydrogenase complex-E2 by apoptosis-related proteases. Hepatology. 35:(1):2002;14-22.
15. Bantel H., Lugering A., Poremba C., et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology. 34:(4 Part 1):2001;758-767.
16. Rivero M., Crespo J., Fabrega E., et al. Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus. J Viral Hepatitis. 9:2002;107-113.
17. Zhu N., Khoshnan A., Schneider R., et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol. 72:1998;3691-3697.
18. Otsuka M., Kato N., Taniguchi H., et al. Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression. Virology. 296:2002;84-93.
19. Majumder M., Ghosh A.K., Steele R., et al. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology. 294:2002;94-105.
20. Pan J., Duan L.X., Sun B.S., Feitelson M.A. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B. J Gen Virol. 82:2001;171-182.
21. Chen Q., Galleano M., Cederbaum A.I. Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1. J Biol Chem. 272:1997;14532-14541.
22. Pastorino J.G., Hoek J.B. Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition. Hepatology. 31:2000;1141-1152.
23. Mehal W.Z., Juedes A.E., Crispe I.N. Selective retention of activated CD8+ T cells by the normal liver. J Immunol. 163:(6):1999;3202-3210.
24. Bertolino P., Heath W.R., Hardy C.L., Morahan G., Miller J.F. Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol. 25:(7):1995;1932-1942.
25. Dini L., Lentini A., Diez G.D., et al. Phagocytosis of apoptotic bodies by liver endothelial cells. J Cell Sci. 108:1995;967-973.
26. McVicker B.L., Casey C.A. Effects of ethanol on receptor-mediated endocytosis in the liver. Alcohol. 19:1999;255-260.
27. Viitala K., Makkonen K., Israel Y., et al. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers. Alcohol Clin Exp Res. 24:(7):2000;1103-1109.
28. Cohen P.L., Caricchio R., Abraham V., et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med. 196:(1):2002;135-140.
29. Ikeguchi M., Ueda T., Sakatani T., Hirooka Y., Kaibara N. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol. 11:(1):2002;33-40.
30. Takehara T., Liu X., Fujimoto J., Friedman S.L., Takahashi H. Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology. 34:(1):2001;55-61.
31. Ito Y., Takeda T., Sasaki Y., et al. Expression of Fas and Fas ligand reflects the biological characteristics but not the status of apoptosis of intrahepatic cholangiocellular carcinoma. Int J Mol Med. 6:(5):2000;581-586.
32. Lee S.H., Shin M.S., Lee H.S., et al. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum Pathol. 32:(3):2001;250-256.
33. Nzeako U.C., Guicciardi M.E., Yoon J.H., Bronk S.F., Gores G.J. COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells. Hepatology. 35:(3):2002;552-559.
34. Ahn E.Y., Pan G., Vickers S.M., McDonald J.M. IFN-gamma upregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. Int J Cancer. 100:(4):2002;445-451.
35. Okaro A.C., Fennell D.A., Corbo M., Davidson B.R., Cotter F.E. Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells. Gut. 51:(4):2002;556-561.
36. Knolle P.A., Gerken G. Local control of the immune response in the liver. Immunol Rev. 174:2000;21-34. Review.
37. Bertolino P., Trescol-Biemont M.C., Rabourdin-Combe C. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur J Immunol. 28:(1):1998;221-236.
38. Nawaz S., Fennell R.H. Apoptosis of bile duct epithelial cells in hepatic allograft rejection. Histopathology. 25:(2):1994;137-142.
39. Gapany C., Zhao M., Zimmermann A. The apoptosis protector, bcl-2 protein, is downregulated in bile duct epithelial cells of human liver allografts. J Hepatol. 26:(3):1997;535-542.